Evidence map›Paper›PMID 41607374›Full record

ArticleFrontiers in surgery2025

Late-onset anti-Yo antibody-positive paraneoplastic cerebellar degeneration: a case report.

Zhang Zhenyu, Guo Man, Zhao Guohui, Li Chenglong, Ma Yong, Zhou Jie, Cai Zhibiao

Abstract readCase Reports
In one paragraph

Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zhang ZhenyuDepartment of Neurosurgery, The 940th Hospital of Joint Logistics Support Force of the Chinese PLA, Lanzhou, Gansu, China.
Guo ManDepartment of Neurosurgery, The 940th Hospital of Joint Logistics Support Force of the Chinese PLA, Lanzhou, Gansu, China.
Zhao GuohuiDepartment of Neurosurgery, The 940th Hospital of Joint Logistics Support Force of the Chinese PLA, Lanzhou, Gansu, China.
Li ChenglongDepartment of Neurosurgery, The 940th Hospital of Joint Logistics Support Force of the Chinese PLA, Lanzhou, Gansu, China.
Ma YongDepartment of Neurosurgery, The 940th Hospital of Joint Logistics Support Force of the Chinese PLA, Lanzhou, Gansu, China.
Zhou JieDepartment of Neurosurgery, The 940th Hospital of Joint Logistics Support Force of the Chinese PLA, Lanzhou, Gansu, China.
Cai ZhibiaoDepartment of Neurosurgery, The 940th Hospital of Joint Logistics Support Force of the Chinese PLA, Lanzhou, Gansu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anti-Yo antibody-positive paraneoplastic cerebellar degeneration (PCD) is a rare immune-mediated neurological syndrome associated with malignancy, presenting significant diagnostic and therapeutic challenges. This case describes an elderly female patient who developed delayed-onset subacute cerebellar symptoms three years after ovarian cancer resection, ultimately diagnosed with anti-Yo antibody-positive PCD. Although immunotherapy was administered, the patient's ataxia exhibited only limited improvement, suggesting that PCD may progress to an irreversible pathological stage. This case challenges the conventional understanding that PCD typically precedes tumour detection, offering a new perspective on clinical diagnosis and management due to the three-year interval. This case underscores the importance of considering paraneoplastic etiology in patients with unexplained neurological deficits who have a history of tumor surgery. Maintaining awareness for long-term screening for PCD and early management of primary malignancies alongside immunological interventions is crucial for delaying disease progression.

Indexed as

anti-Yo antibodyataxiacancerlate-onsetovarianparaneoplastic cerebellar degenerationvertigo

Identifiers

PMID41607374
PMCPMC12835388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.